These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8891323)

  • 1. Medroxyprogesterone and paraphiles: do testosterone levels matter?
    Kravitz HM; Haywood TW; Kelly J; Liles S; Cavanaugh JL
    Bull Am Acad Psychiatry Law; 1996; 24(1):73-83. PubMed ID: 8891323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medroxyprogesterone treatment for paraphiliacs.
    Kravitz HM; Haywood TW; Kelly J; Wahlstrom C; Liles S; Cavanaugh JL
    Bull Am Acad Psychiatry Law; 1995; 23(1):19-33. PubMed ID: 7599368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias.
    Gottesman HG; Schubert DS
    J Clin Psychiatry; 1993 May; 54(5):182-8. PubMed ID: 8509348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depo provera treatment for sex offending behavior: an evaluation of outcome.
    Meyer WJ; Cole C; Emory E
    Bull Am Acad Psychiatry Law; 1992; 20(3):249-59. PubMed ID: 1421556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of paraphilic and nonparaphilic sexual disorders.
    Guay DR
    Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.
    Massengill JC; Sun L; Moul JW; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Donahue T
    J Urol; 2003 May; 169(5):1670-5. PubMed ID: 12686805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
    Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
    Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
    J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing antilibidinal treatment with medroxyprogesterone acetate.
    Stewart JT
    J Am Geriatr Soc; 2005 Feb; 53(2):359-60. PubMed ID: 15673373
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of depo-provera in the treatment of aggressive sexual offenders: preliminary report of three cases.
    Barry DJ; Ciccone JR
    Bull Am Acad Psychiatry Law; 1975; 3(3):179-84. PubMed ID: 1230194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire.
    van Anders SM; Chernick AB; Chernick BA; Hampson E; Fisher WA
    J Sex Marital Ther; 2005; 31(3):173-85. PubMed ID: 16020137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous serum testosterone in males after different doses and routes of administration of medroxyprogesterone acetate.
    Novak E; Hendrix JW; Seckman CE; Kaiser DG; Stoll RG
    J Reprod Med; 1980 Oct; 25(4):157-60. PubMed ID: 7431362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of sex offenders with Depo-Provera.
    Kiersch TA
    Bull Am Acad Psychiatry Law; 1990; 18(2):179-87. PubMed ID: 2142608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged effects of intra-nasally administered testosterone on proceptive behavior in female capuchin monkeys (Cebus apella).
    Topic B; Tavares MC; Tomaz C; Mattern C
    Behav Brain Res; 2007 Apr; 179(1):60-8. PubMed ID: 17306379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.